Global Hirudin Supply, Demand and Key Producers, 2026-2032
The global Hirudin market size is expected to reach $ 5491 million by 2032, rising at a market growth of 3.0% CAGR during the forecast period (2026-2032).
Hirudin is a potent anticoagulant protein originally derived from the salivary glands of the medicinal leech (Hirudo medicinalis). Its mechanism of action involves directly binding to thrombin, the enzyme responsible for converting fibrinogen into fibrin during the clotting process, thus preventing blood coagulation. This unique property makes hirudin a highly effective anticoagulant, especially in patients at risk of thrombus formation. With the advancement of biotechnology, the production of hirudin has shifted from being sourced directly from leeches to large-scale synthesis through recombinant DNA technology in laboratories. Currently, hirudin is primarily used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and certain types of strokes. It is considered an effective alternative for patients who are allergic or intolerant to traditional anticoagulants like heparin. Over the years, with increasing research into hirudin’s applications, various derivatives and related drugs, such as lepirudin and desirudin, have been developed, broadening its clinical use.
The market development of hirudin is driven by several factors. Firstly, the growing global demand for the treatment of thrombotic diseases, particularly among cardiovascular patients and post-surgical individuals, presents significant opportunities for hirudin and its derivatives. With the aging population and the increasing prevalence of thrombotic and vascular diseases, there is a rising demand for effective anticoagulants. Secondly, hirudin's unique mechanism of action offers advantages in treating certain conditions, particularly for patients who are allergic to traditional anticoagulants like heparin, further driving the market for hirudin products.
However, the hirudin market faces challenges and risks. The production cost remains high, particularly in the early stages when biotechnology was not fully developed, limiting its widespread use. Additionally, although hirudin has strong anticoagulant effects, its use requires careful monitoring of the patient's coagulation function to prevent the risk of bleeding.
In terms of market concentration, as production technologies for hirudin mature, the market has become more concentrated in the hands of a few large pharmaceutical companies that maintain their market share through acquisitions, research and development, and patented technologies. The downstream demand trend is diversifying, with hirudin finding applications not only in traditional thrombotic disease treatment but also in other coagulation disorders and post-surgical care. Recent technological advances include the recombinant production of hirudin using genetic engineering, which has significantly improved production efficiency and lowered costs, potentially expanding the use of hirudin in the future.
This report studies the global Hirudin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hirudin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hirudin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hirudin total production and demand, 2021-2032, (Tons)
Global Hirudin total production value, 2021-2032, (USD Million)
Global Hirudin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Hirudin consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Hirudin domestic production, consumption, key domestic manufacturers and share
Global Hirudin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Hirudin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Hirudin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Hirudin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Teva Pharmaceuticals, Pfizer, Inc, Pentapharm, DUOPUTAI, Abbott, Keyken, Minapharm, Salubris Bio, Hoechst AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hirudin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Hirudin Market, By Region:
1. How big is the global Hirudin market?
2. What is the demand of the global Hirudin market?
3. What is the year over year growth of the global Hirudin market?
4. What is the production and production value of the global Hirudin market?
5. Who are the key producers in the global Hirudin market?
6. What are the growth factors driving the market demand?
Hirudin is a potent anticoagulant protein originally derived from the salivary glands of the medicinal leech (Hirudo medicinalis). Its mechanism of action involves directly binding to thrombin, the enzyme responsible for converting fibrinogen into fibrin during the clotting process, thus preventing blood coagulation. This unique property makes hirudin a highly effective anticoagulant, especially in patients at risk of thrombus formation. With the advancement of biotechnology, the production of hirudin has shifted from being sourced directly from leeches to large-scale synthesis through recombinant DNA technology in laboratories. Currently, hirudin is primarily used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and certain types of strokes. It is considered an effective alternative for patients who are allergic or intolerant to traditional anticoagulants like heparin. Over the years, with increasing research into hirudin’s applications, various derivatives and related drugs, such as lepirudin and desirudin, have been developed, broadening its clinical use.
The market development of hirudin is driven by several factors. Firstly, the growing global demand for the treatment of thrombotic diseases, particularly among cardiovascular patients and post-surgical individuals, presents significant opportunities for hirudin and its derivatives. With the aging population and the increasing prevalence of thrombotic and vascular diseases, there is a rising demand for effective anticoagulants. Secondly, hirudin's unique mechanism of action offers advantages in treating certain conditions, particularly for patients who are allergic to traditional anticoagulants like heparin, further driving the market for hirudin products.
However, the hirudin market faces challenges and risks. The production cost remains high, particularly in the early stages when biotechnology was not fully developed, limiting its widespread use. Additionally, although hirudin has strong anticoagulant effects, its use requires careful monitoring of the patient's coagulation function to prevent the risk of bleeding.
In terms of market concentration, as production technologies for hirudin mature, the market has become more concentrated in the hands of a few large pharmaceutical companies that maintain their market share through acquisitions, research and development, and patented technologies. The downstream demand trend is diversifying, with hirudin finding applications not only in traditional thrombotic disease treatment but also in other coagulation disorders and post-surgical care. Recent technological advances include the recombinant production of hirudin using genetic engineering, which has significantly improved production efficiency and lowered costs, potentially expanding the use of hirudin in the future.
This report studies the global Hirudin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hirudin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hirudin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hirudin total production and demand, 2021-2032, (Tons)
Global Hirudin total production value, 2021-2032, (USD Million)
Global Hirudin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Hirudin consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Hirudin domestic production, consumption, key domestic manufacturers and share
Global Hirudin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Hirudin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Hirudin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Hirudin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Teva Pharmaceuticals, Pfizer, Inc, Pentapharm, DUOPUTAI, Abbott, Keyken, Minapharm, Salubris Bio, Hoechst AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hirudin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Hirudin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Natural Hirudin
- Recombinant Hirudin
- Thrombosis Disease
- Tumor Disease
- Others
- Novartis
- Teva Pharmaceuticals
- Pfizer, Inc
- Pentapharm
- DUOPUTAI
- Abbott
- Keyken
- Minapharm
- Salubris Bio
- Hoechst AG
- Ciba-Geigy
- Boehringer Ingelheim
- Sanofi
- Xellia Pharmaceuticals
- Haplogen Pharmaceuticals
- Shenzhen Kangtai Biological
- Dong-A ST
1. How big is the global Hirudin market?
2. What is the demand of the global Hirudin market?
3. What is the year over year growth of the global Hirudin market?
4. What is the production and production value of the global Hirudin market?
5. Who are the key producers in the global Hirudin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Hirudin Introduction
1.2 World Hirudin Supply & Forecast
1.2.1 World Hirudin Production Value (2021 & 2025 & 2032)
1.2.2 World Hirudin Production (2021-2032)
1.2.3 World Hirudin Pricing Trends (2021-2032)
1.3 World Hirudin Production by Region (Based on Production Site)
1.3.1 World Hirudin Production Value by Region (2021-2032)
1.3.2 World Hirudin Production by Region (2021-2032)
1.3.3 World Hirudin Average Price by Region (2021-2032)
1.3.4 North America Hirudin Production (2021-2032)
1.3.5 Europe Hirudin Production (2021-2032)
1.3.6 China Hirudin Production (2021-2032)
1.3.7 Japan Hirudin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hirudin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hirudin Major Market Trends
2 DEMAND SUMMARY
2.1 World Hirudin Demand (2021-2032)
2.2 World Hirudin Consumption by Region
2.2.1 World Hirudin Consumption by Region (2021-2026)
2.2.2 World Hirudin Consumption Forecast by Region (2027-2032)
2.3 United States Hirudin Consumption (2021-2032)
2.4 China Hirudin Consumption (2021-2032)
2.5 Europe Hirudin Consumption (2021-2032)
2.6 Japan Hirudin Consumption (2021-2032)
2.7 South Korea Hirudin Consumption (2021-2032)
2.8 ASEAN Hirudin Consumption (2021-2032)
2.9 India Hirudin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hirudin Production Value by Manufacturer (2021-2026)
3.2 World Hirudin Production by Manufacturer (2021-2026)
3.3 World Hirudin Average Price by Manufacturer (2021-2026)
3.4 Hirudin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hirudin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hirudin in 2025
3.5.3 Global Concentration Ratios (CR8) for Hirudin in 2025
3.6 Hirudin Market: Overall Company Footprint Analysis
3.6.1 Hirudin Market: Region Footprint
3.6.2 Hirudin Market: Company Product Type Footprint
3.6.3 Hirudin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hirudin Production Value Comparison
4.1.1 United States VS China: Hirudin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Hirudin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Hirudin Production Comparison
4.2.1 United States VS China: Hirudin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Hirudin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Hirudin Consumption Comparison
4.3.1 United States VS China: Hirudin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Hirudin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Hirudin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hirudin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Hirudin Production (2021-2026)
4.5 China Based Hirudin Manufacturers and Market Share
4.5.1 China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hirudin Production Value (2021-2026)
4.5.3 China Based Manufacturers Hirudin Production (2021-2026)
4.6 Rest of World Based Hirudin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hirudin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Hirudin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Hirudin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Natural Hirudin
5.2.2 Recombinant Hirudin
5.3 Market Segment by Type
5.3.1 World Hirudin Production by Type (2021-2032)
5.3.2 World Hirudin Production Value by Type (2021-2032)
5.3.3 World Hirudin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hirudin Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Thrombosis Disease
6.2.2 Tumor Disease
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Hirudin Production by Application (2021-2032)
6.3.2 World Hirudin Production Value by Application (2021-2032)
6.3.3 World Hirudin Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Hirudin Product and Services
7.1.4 Novartis Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Details
7.2.2 Teva Pharmaceuticals Major Business
7.2.3 Teva Pharmaceuticals Hirudin Product and Services
7.2.4 Teva Pharmaceuticals Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Teva Pharmaceuticals Recent Developments/Updates
7.2.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Details
7.3.2 Pfizer, Inc Major Business
7.3.3 Pfizer, Inc Hirudin Product and Services
7.3.4 Pfizer, Inc Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Pfizer, Inc Recent Developments/Updates
7.3.6 Pfizer, Inc Competitive Strengths & Weaknesses
7.4 Pentapharm
7.4.1 Pentapharm Details
7.4.2 Pentapharm Major Business
7.4.3 Pentapharm Hirudin Product and Services
7.4.4 Pentapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Pentapharm Recent Developments/Updates
7.4.6 Pentapharm Competitive Strengths & Weaknesses
7.5 DUOPUTAI
7.5.1 DUOPUTAI Details
7.5.2 DUOPUTAI Major Business
7.5.3 DUOPUTAI Hirudin Product and Services
7.5.4 DUOPUTAI Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 DUOPUTAI Recent Developments/Updates
7.5.6 DUOPUTAI Competitive Strengths & Weaknesses
7.6 Abbott
7.6.1 Abbott Details
7.6.2 Abbott Major Business
7.6.3 Abbott Hirudin Product and Services
7.6.4 Abbott Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Abbott Recent Developments/Updates
7.6.6 Abbott Competitive Strengths & Weaknesses
7.7 Keyken
7.7.1 Keyken Details
7.7.2 Keyken Major Business
7.7.3 Keyken Hirudin Product and Services
7.7.4 Keyken Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Keyken Recent Developments/Updates
7.7.6 Keyken Competitive Strengths & Weaknesses
7.8 Minapharm
7.8.1 Minapharm Details
7.8.2 Minapharm Major Business
7.8.3 Minapharm Hirudin Product and Services
7.8.4 Minapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Minapharm Recent Developments/Updates
7.8.6 Minapharm Competitive Strengths & Weaknesses
7.9 Salubris Bio
7.9.1 Salubris Bio Details
7.9.2 Salubris Bio Major Business
7.9.3 Salubris Bio Hirudin Product and Services
7.9.4 Salubris Bio Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Salubris Bio Recent Developments/Updates
7.9.6 Salubris Bio Competitive Strengths & Weaknesses
7.10 Hoechst AG
7.10.1 Hoechst AG Details
7.10.2 Hoechst AG Major Business
7.10.3 Hoechst AG Hirudin Product and Services
7.10.4 Hoechst AG Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Hoechst AG Recent Developments/Updates
7.10.6 Hoechst AG Competitive Strengths & Weaknesses
7.11 Ciba-Geigy
7.11.1 Ciba-Geigy Details
7.11.2 Ciba-Geigy Major Business
7.11.3 Ciba-Geigy Hirudin Product and Services
7.11.4 Ciba-Geigy Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Ciba-Geigy Recent Developments/Updates
7.11.6 Ciba-Geigy Competitive Strengths & Weaknesses
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Details
7.12.2 Boehringer Ingelheim Major Business
7.12.3 Boehringer Ingelheim Hirudin Product and Services
7.12.4 Boehringer Ingelheim Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Boehringer Ingelheim Recent Developments/Updates
7.12.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.13 Sanofi
7.13.1 Sanofi Details
7.13.2 Sanofi Major Business
7.13.3 Sanofi Hirudin Product and Services
7.13.4 Sanofi Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Sanofi Recent Developments/Updates
7.13.6 Sanofi Competitive Strengths & Weaknesses
7.14 Xellia Pharmaceuticals
7.14.1 Xellia Pharmaceuticals Details
7.14.2 Xellia Pharmaceuticals Major Business
7.14.3 Xellia Pharmaceuticals Hirudin Product and Services
7.14.4 Xellia Pharmaceuticals Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Xellia Pharmaceuticals Recent Developments/Updates
7.14.6 Xellia Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Haplogen Pharmaceuticals
7.15.1 Haplogen Pharmaceuticals Details
7.15.2 Haplogen Pharmaceuticals Major Business
7.15.3 Haplogen Pharmaceuticals Hirudin Product and Services
7.15.4 Haplogen Pharmaceuticals Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Haplogen Pharmaceuticals Recent Developments/Updates
7.15.6 Haplogen Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Shenzhen Kangtai Biological
7.16.1 Shenzhen Kangtai Biological Details
7.16.2 Shenzhen Kangtai Biological Major Business
7.16.3 Shenzhen Kangtai Biological Hirudin Product and Services
7.16.4 Shenzhen Kangtai Biological Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 Shenzhen Kangtai Biological Recent Developments/Updates
7.16.6 Shenzhen Kangtai Biological Competitive Strengths & Weaknesses
7.17 Dong-A ST
7.17.1 Dong-A ST Details
7.17.2 Dong-A ST Major Business
7.17.3 Dong-A ST Hirudin Product and Services
7.17.4 Dong-A ST Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.17.5 Dong-A ST Recent Developments/Updates
7.17.6 Dong-A ST Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hirudin Industry Chain
8.2 Hirudin Upstream Analysis
8.2.1 Hirudin Core Raw Materials
8.2.2 Main Manufacturers of Hirudin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hirudin Production Mode
8.6 Hirudin Procurement Model
8.7 Hirudin Industry Sales Model and Sales Channels
8.7.1 Hirudin Sales Model
8.7.2 Hirudin Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Hirudin Introduction
1.2 World Hirudin Supply & Forecast
1.2.1 World Hirudin Production Value (2021 & 2025 & 2032)
1.2.2 World Hirudin Production (2021-2032)
1.2.3 World Hirudin Pricing Trends (2021-2032)
1.3 World Hirudin Production by Region (Based on Production Site)
1.3.1 World Hirudin Production Value by Region (2021-2032)
1.3.2 World Hirudin Production by Region (2021-2032)
1.3.3 World Hirudin Average Price by Region (2021-2032)
1.3.4 North America Hirudin Production (2021-2032)
1.3.5 Europe Hirudin Production (2021-2032)
1.3.6 China Hirudin Production (2021-2032)
1.3.7 Japan Hirudin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hirudin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hirudin Major Market Trends
2 DEMAND SUMMARY
2.1 World Hirudin Demand (2021-2032)
2.2 World Hirudin Consumption by Region
2.2.1 World Hirudin Consumption by Region (2021-2026)
2.2.2 World Hirudin Consumption Forecast by Region (2027-2032)
2.3 United States Hirudin Consumption (2021-2032)
2.4 China Hirudin Consumption (2021-2032)
2.5 Europe Hirudin Consumption (2021-2032)
2.6 Japan Hirudin Consumption (2021-2032)
2.7 South Korea Hirudin Consumption (2021-2032)
2.8 ASEAN Hirudin Consumption (2021-2032)
2.9 India Hirudin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hirudin Production Value by Manufacturer (2021-2026)
3.2 World Hirudin Production by Manufacturer (2021-2026)
3.3 World Hirudin Average Price by Manufacturer (2021-2026)
3.4 Hirudin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hirudin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hirudin in 2025
3.5.3 Global Concentration Ratios (CR8) for Hirudin in 2025
3.6 Hirudin Market: Overall Company Footprint Analysis
3.6.1 Hirudin Market: Region Footprint
3.6.2 Hirudin Market: Company Product Type Footprint
3.6.3 Hirudin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hirudin Production Value Comparison
4.1.1 United States VS China: Hirudin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Hirudin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Hirudin Production Comparison
4.2.1 United States VS China: Hirudin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Hirudin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Hirudin Consumption Comparison
4.3.1 United States VS China: Hirudin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Hirudin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Hirudin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hirudin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Hirudin Production (2021-2026)
4.5 China Based Hirudin Manufacturers and Market Share
4.5.1 China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hirudin Production Value (2021-2026)
4.5.3 China Based Manufacturers Hirudin Production (2021-2026)
4.6 Rest of World Based Hirudin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hirudin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Hirudin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Hirudin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Natural Hirudin
5.2.2 Recombinant Hirudin
5.3 Market Segment by Type
5.3.1 World Hirudin Production by Type (2021-2032)
5.3.2 World Hirudin Production Value by Type (2021-2032)
5.3.3 World Hirudin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hirudin Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Thrombosis Disease
6.2.2 Tumor Disease
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Hirudin Production by Application (2021-2032)
6.3.2 World Hirudin Production Value by Application (2021-2032)
6.3.3 World Hirudin Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Hirudin Product and Services
7.1.4 Novartis Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Details
7.2.2 Teva Pharmaceuticals Major Business
7.2.3 Teva Pharmaceuticals Hirudin Product and Services
7.2.4 Teva Pharmaceuticals Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Teva Pharmaceuticals Recent Developments/Updates
7.2.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Details
7.3.2 Pfizer, Inc Major Business
7.3.3 Pfizer, Inc Hirudin Product and Services
7.3.4 Pfizer, Inc Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Pfizer, Inc Recent Developments/Updates
7.3.6 Pfizer, Inc Competitive Strengths & Weaknesses
7.4 Pentapharm
7.4.1 Pentapharm Details
7.4.2 Pentapharm Major Business
7.4.3 Pentapharm Hirudin Product and Services
7.4.4 Pentapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Pentapharm Recent Developments/Updates
7.4.6 Pentapharm Competitive Strengths & Weaknesses
7.5 DUOPUTAI
7.5.1 DUOPUTAI Details
7.5.2 DUOPUTAI Major Business
7.5.3 DUOPUTAI Hirudin Product and Services
7.5.4 DUOPUTAI Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 DUOPUTAI Recent Developments/Updates
7.5.6 DUOPUTAI Competitive Strengths & Weaknesses
7.6 Abbott
7.6.1 Abbott Details
7.6.2 Abbott Major Business
7.6.3 Abbott Hirudin Product and Services
7.6.4 Abbott Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Abbott Recent Developments/Updates
7.6.6 Abbott Competitive Strengths & Weaknesses
7.7 Keyken
7.7.1 Keyken Details
7.7.2 Keyken Major Business
7.7.3 Keyken Hirudin Product and Services
7.7.4 Keyken Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Keyken Recent Developments/Updates
7.7.6 Keyken Competitive Strengths & Weaknesses
7.8 Minapharm
7.8.1 Minapharm Details
7.8.2 Minapharm Major Business
7.8.3 Minapharm Hirudin Product and Services
7.8.4 Minapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Minapharm Recent Developments/Updates
7.8.6 Minapharm Competitive Strengths & Weaknesses
7.9 Salubris Bio
7.9.1 Salubris Bio Details
7.9.2 Salubris Bio Major Business
7.9.3 Salubris Bio Hirudin Product and Services
7.9.4 Salubris Bio Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Salubris Bio Recent Developments/Updates
7.9.6 Salubris Bio Competitive Strengths & Weaknesses
7.10 Hoechst AG
7.10.1 Hoechst AG Details
7.10.2 Hoechst AG Major Business
7.10.3 Hoechst AG Hirudin Product and Services
7.10.4 Hoechst AG Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Hoechst AG Recent Developments/Updates
7.10.6 Hoechst AG Competitive Strengths & Weaknesses
7.11 Ciba-Geigy
7.11.1 Ciba-Geigy Details
7.11.2 Ciba-Geigy Major Business
7.11.3 Ciba-Geigy Hirudin Product and Services
7.11.4 Ciba-Geigy Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Ciba-Geigy Recent Developments/Updates
7.11.6 Ciba-Geigy Competitive Strengths & Weaknesses
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Details
7.12.2 Boehringer Ingelheim Major Business
7.12.3 Boehringer Ingelheim Hirudin Product and Services
7.12.4 Boehringer Ingelheim Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Boehringer Ingelheim Recent Developments/Updates
7.12.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.13 Sanofi
7.13.1 Sanofi Details
7.13.2 Sanofi Major Business
7.13.3 Sanofi Hirudin Product and Services
7.13.4 Sanofi Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Sanofi Recent Developments/Updates
7.13.6 Sanofi Competitive Strengths & Weaknesses
7.14 Xellia Pharmaceuticals
7.14.1 Xellia Pharmaceuticals Details
7.14.2 Xellia Pharmaceuticals Major Business
7.14.3 Xellia Pharmaceuticals Hirudin Product and Services
7.14.4 Xellia Pharmaceuticals Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Xellia Pharmaceuticals Recent Developments/Updates
7.14.6 Xellia Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Haplogen Pharmaceuticals
7.15.1 Haplogen Pharmaceuticals Details
7.15.2 Haplogen Pharmaceuticals Major Business
7.15.3 Haplogen Pharmaceuticals Hirudin Product and Services
7.15.4 Haplogen Pharmaceuticals Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Haplogen Pharmaceuticals Recent Developments/Updates
7.15.6 Haplogen Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Shenzhen Kangtai Biological
7.16.1 Shenzhen Kangtai Biological Details
7.16.2 Shenzhen Kangtai Biological Major Business
7.16.3 Shenzhen Kangtai Biological Hirudin Product and Services
7.16.4 Shenzhen Kangtai Biological Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 Shenzhen Kangtai Biological Recent Developments/Updates
7.16.6 Shenzhen Kangtai Biological Competitive Strengths & Weaknesses
7.17 Dong-A ST
7.17.1 Dong-A ST Details
7.17.2 Dong-A ST Major Business
7.17.3 Dong-A ST Hirudin Product and Services
7.17.4 Dong-A ST Hirudin Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.17.5 Dong-A ST Recent Developments/Updates
7.17.6 Dong-A ST Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hirudin Industry Chain
8.2 Hirudin Upstream Analysis
8.2.1 Hirudin Core Raw Materials
8.2.2 Main Manufacturers of Hirudin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hirudin Production Mode
8.6 Hirudin Procurement Model
8.7 Hirudin Industry Sales Model and Sales Channels
8.7.1 Hirudin Sales Model
8.7.2 Hirudin Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Hirudin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Hirudin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Hirudin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Hirudin Production Value Market Share by Region (2021-2026)
Table 5. World Hirudin Production Value Market Share by Region (2027-2032)
Table 6. World Hirudin Production by Region (2021-2026) & (Tons)
Table 7. World Hirudin Production by Region (2027-2032) & (Tons)
Table 8. World Hirudin Production Market Share by Region (2021-2026)
Table 9. World Hirudin Production Market Share by Region (2027-2032)
Table 10. World Hirudin Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Hirudin Average Price by Region (2027-2032) & (US$/kg)
Table 12. Hirudin Major Market Trends
Table 13. World Hirudin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Hirudin Consumption by Region (2021-2026) & (Tons)
Table 15. World Hirudin Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Hirudin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Hirudin Producers in 2025
Table 18. World Hirudin Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Hirudin Producers in 2025
Table 20. World Hirudin Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Hirudin Company Evaluation Quadrant
Table 22. World Hirudin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Hirudin Production Site of Key Manufacturer
Table 24. Hirudin Market: Company Product Type Footprint
Table 25. Hirudin Market: Company Product Application Footprint
Table 26. Hirudin Competitive Factors
Table 27. Hirudin New Entrant and Capacity Expansion Plans
Table 28. Hirudin Mergers & Acquisitions Activity
Table 29. United States VS China Hirudin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Hirudin Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Hirudin Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hirudin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Hirudin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Hirudin Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Hirudin Production Market Share (2021-2026)
Table 37. China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hirudin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Hirudin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Hirudin Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Hirudin Production Market Share (2021-2026)
Table 42. Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Hirudin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Hirudin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Hirudin Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Hirudin Production Market Share (2021-2026)
Table 47. World Hirudin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Hirudin Production by Type (2021-2026) & (Tons)
Table 49. World Hirudin Production by Type (2027-2032) & (Tons)
Table 50. World Hirudin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Hirudin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Hirudin Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Hirudin Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Hirudin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Hirudin Production by Application (2021-2026) & (Tons)
Table 56. World Hirudin Production by Application (2027-2032) & (Tons)
Table 57. World Hirudin Production Value by Application (2021-2026) & (USD Million)
Table 58. World Hirudin Production Value by Application (2027-2032) & (USD Million)
Table 59. World Hirudin Average Price by Application (2021-2026) & (US$/kg)
Table 60. World Hirudin Average Price by Application (2027-2032) & (US$/kg)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Hirudin Product and Services
Table 64. Novartis Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceuticals Major Business
Table 69. Teva Pharmaceuticals Hirudin Product and Services
Table 70. Teva Pharmaceuticals Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Teva Pharmaceuticals Recent Developments/Updates
Table 72. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer, Inc Major Business
Table 75. Pfizer, Inc Hirudin Product and Services
Table 76. Pfizer, Inc Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Pfizer, Inc Recent Developments/Updates
Table 78. Pfizer, Inc Competitive Strengths & Weaknesses
Table 79. Pentapharm Basic Information, Manufacturing Base and Competitors
Table 80. Pentapharm Major Business
Table 81. Pentapharm Hirudin Product and Services
Table 82. Pentapharm Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Pentapharm Recent Developments/Updates
Table 84. Pentapharm Competitive Strengths & Weaknesses
Table 85. DUOPUTAI Basic Information, Manufacturing Base and Competitors
Table 86. DUOPUTAI Major Business
Table 87. DUOPUTAI Hirudin Product and Services
Table 88. DUOPUTAI Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. DUOPUTAI Recent Developments/Updates
Table 90. DUOPUTAI Competitive Strengths & Weaknesses
Table 91. Abbott Basic Information, Manufacturing Base and Competitors
Table 92. Abbott Major Business
Table 93. Abbott Hirudin Product and Services
Table 94. Abbott Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Abbott Recent Developments/Updates
Table 96. Abbott Competitive Strengths & Weaknesses
Table 97. Keyken Basic Information, Manufacturing Base and Competitors
Table 98. Keyken Major Business
Table 99. Keyken Hirudin Product and Services
Table 100. Keyken Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Keyken Recent Developments/Updates
Table 102. Keyken Competitive Strengths & Weaknesses
Table 103. Minapharm Basic Information, Manufacturing Base and Competitors
Table 104. Minapharm Major Business
Table 105. Minapharm Hirudin Product and Services
Table 106. Minapharm Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Minapharm Recent Developments/Updates
Table 108. Minapharm Competitive Strengths & Weaknesses
Table 109. Salubris Bio Basic Information, Manufacturing Base and Competitors
Table 110. Salubris Bio Major Business
Table 111. Salubris Bio Hirudin Product and Services
Table 112. Salubris Bio Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Salubris Bio Recent Developments/Updates
Table 114. Salubris Bio Competitive Strengths & Weaknesses
Table 115. Hoechst AG Basic Information, Manufacturing Base and Competitors
Table 116. Hoechst AG Major Business
Table 117. Hoechst AG Hirudin Product and Services
Table 118. Hoechst AG Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Hoechst AG Recent Developments/Updates
Table 120. Hoechst AG Competitive Strengths & Weaknesses
Table 121. Ciba-Geigy Basic Information, Manufacturing Base and Competitors
Table 122. Ciba-Geigy Major Business
Table 123. Ciba-Geigy Hirudin Product and Services
Table 124. Ciba-Geigy Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Ciba-Geigy Recent Developments/Updates
Table 126. Ciba-Geigy Competitive Strengths & Weaknesses
Table 127. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 128. Boehringer Ingelheim Major Business
Table 129. Boehringer Ingelheim Hirudin Product and Services
Table 130. Boehringer Ingelheim Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Boehringer Ingelheim Recent Developments/Updates
Table 132. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 133. Sanofi Basic Information, Manufacturing Base and Competitors
Table 134. Sanofi Major Business
Table 135. Sanofi Hirudin Product and Services
Table 136. Sanofi Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Sanofi Recent Developments/Updates
Table 138. Sanofi Competitive Strengths & Weaknesses
Table 139. Xellia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 140. Xellia Pharmaceuticals Major Business
Table 141. Xellia Pharmaceuticals Hirudin Product and Services
Table 142. Xellia Pharmaceuticals Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Xellia Pharmaceuticals Recent Developments/Updates
Table 144. Xellia Pharmaceuticals Competitive Strengths & Weaknesses
Table 145. Haplogen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Haplogen Pharmaceuticals Major Business
Table 147. Haplogen Pharmaceuticals Hirudin Product and Services
Table 148. Haplogen Pharmaceuticals Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Haplogen Pharmaceuticals Recent Developments/Updates
Table 150. Haplogen Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Shenzhen Kangtai Biological Basic Information, Manufacturing Base and Competitors
Table 152. Shenzhen Kangtai Biological Major Business
Table 153. Shenzhen Kangtai Biological Hirudin Product and Services
Table 154. Shenzhen Kangtai Biological Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Shenzhen Kangtai Biological Recent Developments/Updates
Table 156. Shenzhen Kangtai Biological Competitive Strengths & Weaknesses
Table 157. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 158. Dong-A ST Major Business
Table 159. Dong-A ST Hirudin Product and Services
Table 160. Dong-A ST Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 161. Dong-A ST Recent Developments/Updates
Table 162. Dong-A ST Competitive Strengths & Weaknesses
Table 163. Global Key Players of Hirudin Upstream (Raw Materials)
Table 164. Global Hirudin Typical Customers
Table 165. Hirudin Typical Distributors
Table 1. World Hirudin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Hirudin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Hirudin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Hirudin Production Value Market Share by Region (2021-2026)
Table 5. World Hirudin Production Value Market Share by Region (2027-2032)
Table 6. World Hirudin Production by Region (2021-2026) & (Tons)
Table 7. World Hirudin Production by Region (2027-2032) & (Tons)
Table 8. World Hirudin Production Market Share by Region (2021-2026)
Table 9. World Hirudin Production Market Share by Region (2027-2032)
Table 10. World Hirudin Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Hirudin Average Price by Region (2027-2032) & (US$/kg)
Table 12. Hirudin Major Market Trends
Table 13. World Hirudin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Hirudin Consumption by Region (2021-2026) & (Tons)
Table 15. World Hirudin Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Hirudin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Hirudin Producers in 2025
Table 18. World Hirudin Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Hirudin Producers in 2025
Table 20. World Hirudin Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Hirudin Company Evaluation Quadrant
Table 22. World Hirudin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Hirudin Production Site of Key Manufacturer
Table 24. Hirudin Market: Company Product Type Footprint
Table 25. Hirudin Market: Company Product Application Footprint
Table 26. Hirudin Competitive Factors
Table 27. Hirudin New Entrant and Capacity Expansion Plans
Table 28. Hirudin Mergers & Acquisitions Activity
Table 29. United States VS China Hirudin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Hirudin Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Hirudin Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hirudin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Hirudin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Hirudin Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Hirudin Production Market Share (2021-2026)
Table 37. China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hirudin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Hirudin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Hirudin Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Hirudin Production Market Share (2021-2026)
Table 42. Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Hirudin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Hirudin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Hirudin Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Hirudin Production Market Share (2021-2026)
Table 47. World Hirudin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Hirudin Production by Type (2021-2026) & (Tons)
Table 49. World Hirudin Production by Type (2027-2032) & (Tons)
Table 50. World Hirudin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Hirudin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Hirudin Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Hirudin Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Hirudin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Hirudin Production by Application (2021-2026) & (Tons)
Table 56. World Hirudin Production by Application (2027-2032) & (Tons)
Table 57. World Hirudin Production Value by Application (2021-2026) & (USD Million)
Table 58. World Hirudin Production Value by Application (2027-2032) & (USD Million)
Table 59. World Hirudin Average Price by Application (2021-2026) & (US$/kg)
Table 60. World Hirudin Average Price by Application (2027-2032) & (US$/kg)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Hirudin Product and Services
Table 64. Novartis Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceuticals Major Business
Table 69. Teva Pharmaceuticals Hirudin Product and Services
Table 70. Teva Pharmaceuticals Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Teva Pharmaceuticals Recent Developments/Updates
Table 72. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer, Inc Major Business
Table 75. Pfizer, Inc Hirudin Product and Services
Table 76. Pfizer, Inc Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Pfizer, Inc Recent Developments/Updates
Table 78. Pfizer, Inc Competitive Strengths & Weaknesses
Table 79. Pentapharm Basic Information, Manufacturing Base and Competitors
Table 80. Pentapharm Major Business
Table 81. Pentapharm Hirudin Product and Services
Table 82. Pentapharm Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Pentapharm Recent Developments/Updates
Table 84. Pentapharm Competitive Strengths & Weaknesses
Table 85. DUOPUTAI Basic Information, Manufacturing Base and Competitors
Table 86. DUOPUTAI Major Business
Table 87. DUOPUTAI Hirudin Product and Services
Table 88. DUOPUTAI Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. DUOPUTAI Recent Developments/Updates
Table 90. DUOPUTAI Competitive Strengths & Weaknesses
Table 91. Abbott Basic Information, Manufacturing Base and Competitors
Table 92. Abbott Major Business
Table 93. Abbott Hirudin Product and Services
Table 94. Abbott Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Abbott Recent Developments/Updates
Table 96. Abbott Competitive Strengths & Weaknesses
Table 97. Keyken Basic Information, Manufacturing Base and Competitors
Table 98. Keyken Major Business
Table 99. Keyken Hirudin Product and Services
Table 100. Keyken Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Keyken Recent Developments/Updates
Table 102. Keyken Competitive Strengths & Weaknesses
Table 103. Minapharm Basic Information, Manufacturing Base and Competitors
Table 104. Minapharm Major Business
Table 105. Minapharm Hirudin Product and Services
Table 106. Minapharm Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Minapharm Recent Developments/Updates
Table 108. Minapharm Competitive Strengths & Weaknesses
Table 109. Salubris Bio Basic Information, Manufacturing Base and Competitors
Table 110. Salubris Bio Major Business
Table 111. Salubris Bio Hirudin Product and Services
Table 112. Salubris Bio Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Salubris Bio Recent Developments/Updates
Table 114. Salubris Bio Competitive Strengths & Weaknesses
Table 115. Hoechst AG Basic Information, Manufacturing Base and Competitors
Table 116. Hoechst AG Major Business
Table 117. Hoechst AG Hirudin Product and Services
Table 118. Hoechst AG Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Hoechst AG Recent Developments/Updates
Table 120. Hoechst AG Competitive Strengths & Weaknesses
Table 121. Ciba-Geigy Basic Information, Manufacturing Base and Competitors
Table 122. Ciba-Geigy Major Business
Table 123. Ciba-Geigy Hirudin Product and Services
Table 124. Ciba-Geigy Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Ciba-Geigy Recent Developments/Updates
Table 126. Ciba-Geigy Competitive Strengths & Weaknesses
Table 127. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 128. Boehringer Ingelheim Major Business
Table 129. Boehringer Ingelheim Hirudin Product and Services
Table 130. Boehringer Ingelheim Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Boehringer Ingelheim Recent Developments/Updates
Table 132. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 133. Sanofi Basic Information, Manufacturing Base and Competitors
Table 134. Sanofi Major Business
Table 135. Sanofi Hirudin Product and Services
Table 136. Sanofi Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Sanofi Recent Developments/Updates
Table 138. Sanofi Competitive Strengths & Weaknesses
Table 139. Xellia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 140. Xellia Pharmaceuticals Major Business
Table 141. Xellia Pharmaceuticals Hirudin Product and Services
Table 142. Xellia Pharmaceuticals Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Xellia Pharmaceuticals Recent Developments/Updates
Table 144. Xellia Pharmaceuticals Competitive Strengths & Weaknesses
Table 145. Haplogen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Haplogen Pharmaceuticals Major Business
Table 147. Haplogen Pharmaceuticals Hirudin Product and Services
Table 148. Haplogen Pharmaceuticals Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Haplogen Pharmaceuticals Recent Developments/Updates
Table 150. Haplogen Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Shenzhen Kangtai Biological Basic Information, Manufacturing Base and Competitors
Table 152. Shenzhen Kangtai Biological Major Business
Table 153. Shenzhen Kangtai Biological Hirudin Product and Services
Table 154. Shenzhen Kangtai Biological Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Shenzhen Kangtai Biological Recent Developments/Updates
Table 156. Shenzhen Kangtai Biological Competitive Strengths & Weaknesses
Table 157. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 158. Dong-A ST Major Business
Table 159. Dong-A ST Hirudin Product and Services
Table 160. Dong-A ST Hirudin Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 161. Dong-A ST Recent Developments/Updates
Table 162. Dong-A ST Competitive Strengths & Weaknesses
Table 163. Global Key Players of Hirudin Upstream (Raw Materials)
Table 164. Global Hirudin Typical Customers
Table 165. Hirudin Typical Distributors
LIST OF FIGURES
Figure 1. Hirudin Picture
Figure 2. World Hirudin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Hirudin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Hirudin Production (2021-2032) & (Tons)
Figure 5. World Hirudin Average Price (2021-2032) & (US$/kg)
Figure 6. World Hirudin Production Value Market Share by Region (2021-2032)
Figure 7. World Hirudin Production Market Share by Region (2021-2032)
Figure 8. North America Hirudin Production (2021-2032) & (Tons)
Figure 9. Europe Hirudin Production (2021-2032) & (Tons)
Figure 10. China Hirudin Production (2021-2032) & (Tons)
Figure 11. Japan Hirudin Production (2021-2032) & (Tons)
Figure 12. Hirudin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hirudin Consumption (2021-2032) & (Tons)
Figure 15. World Hirudin Consumption Market Share by Region (2021-2032)
Figure 16. United States Hirudin Consumption (2021-2032) & (Tons)
Figure 17. China Hirudin Consumption (2021-2032) & (Tons)
Figure 18. Europe Hirudin Consumption (2021-2032) & (Tons)
Figure 19. Japan Hirudin Consumption (2021-2032) & (Tons)
Figure 20. South Korea Hirudin Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Hirudin Consumption (2021-2032) & (Tons)
Figure 22. India Hirudin Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Hirudin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hirudin Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hirudin Markets in 2025
Figure 26. United States VS China: Hirudin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Hirudin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Hirudin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Hirudin Production Market Share 2025
Figure 30. China Based Manufacturers Hirudin Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Hirudin Production Market Share 2025
Figure 32. World Hirudin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Hirudin Production Value Market Share by Type in 2025
Figure 34. Natural Hirudin
Figure 35. Recombinant Hirudin
Figure 36. World Hirudin Production Market Share by Type (2021-2032)
Figure 37. World Hirudin Production Value Market Share by Type (2021-2032)
Figure 38. World Hirudin Average Price by Type (2021-2032) & (US$/kg)
Figure 39. World Hirudin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Hirudin Production Value Market Share by Application in 2025
Figure 41. Thrombosis Disease
Figure 42. Tumor Disease
Figure 43. Others
Figure 44. World Hirudin Production Market Share by Application (2021-2032)
Figure 45. World Hirudin Production Value Market Share by Application (2021-2032)
Figure 46. World Hirudin Average Price by Application (2021-2032) & (US$/kg)
Figure 47. Hirudin Industry Chain
Figure 48. Hirudin Procurement Model
Figure 49. Hirudin Sales Model
Figure 50. Hirudin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Hirudin Picture
Figure 2. World Hirudin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Hirudin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Hirudin Production (2021-2032) & (Tons)
Figure 5. World Hirudin Average Price (2021-2032) & (US$/kg)
Figure 6. World Hirudin Production Value Market Share by Region (2021-2032)
Figure 7. World Hirudin Production Market Share by Region (2021-2032)
Figure 8. North America Hirudin Production (2021-2032) & (Tons)
Figure 9. Europe Hirudin Production (2021-2032) & (Tons)
Figure 10. China Hirudin Production (2021-2032) & (Tons)
Figure 11. Japan Hirudin Production (2021-2032) & (Tons)
Figure 12. Hirudin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hirudin Consumption (2021-2032) & (Tons)
Figure 15. World Hirudin Consumption Market Share by Region (2021-2032)
Figure 16. United States Hirudin Consumption (2021-2032) & (Tons)
Figure 17. China Hirudin Consumption (2021-2032) & (Tons)
Figure 18. Europe Hirudin Consumption (2021-2032) & (Tons)
Figure 19. Japan Hirudin Consumption (2021-2032) & (Tons)
Figure 20. South Korea Hirudin Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Hirudin Consumption (2021-2032) & (Tons)
Figure 22. India Hirudin Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Hirudin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hirudin Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hirudin Markets in 2025
Figure 26. United States VS China: Hirudin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Hirudin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Hirudin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Hirudin Production Market Share 2025
Figure 30. China Based Manufacturers Hirudin Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Hirudin Production Market Share 2025
Figure 32. World Hirudin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Hirudin Production Value Market Share by Type in 2025
Figure 34. Natural Hirudin
Figure 35. Recombinant Hirudin
Figure 36. World Hirudin Production Market Share by Type (2021-2032)
Figure 37. World Hirudin Production Value Market Share by Type (2021-2032)
Figure 38. World Hirudin Average Price by Type (2021-2032) & (US$/kg)
Figure 39. World Hirudin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Hirudin Production Value Market Share by Application in 2025
Figure 41. Thrombosis Disease
Figure 42. Tumor Disease
Figure 43. Others
Figure 44. World Hirudin Production Market Share by Application (2021-2032)
Figure 45. World Hirudin Production Value Market Share by Application (2021-2032)
Figure 46. World Hirudin Average Price by Application (2021-2032) & (US$/kg)
Figure 47. Hirudin Industry Chain
Figure 48. Hirudin Procurement Model
Figure 49. Hirudin Sales Model
Figure 50. Hirudin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
